Global Carmustine Market Analysis by Type (Granulocyte-Colony Stimulating Factor (G-CSF), Long-acting Filgrastim (pegfilgrastim), by Application (Oncology, Hematology,Other conditions causing neutropenia), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by End User (Specialty Clinics, Ambulatory Surgical Centers, Cancer Treatment Centers, Homecare Settings) and by Region: Global Forecast, 2024 - 2034

  • 2024-06-06
  • 241
  • Healthcare & Life Sciences

Market Overview

The Carmustine market is predicted to develop at a compound annual growth rate (CAGR) of 2.84% from 2024 to 2034, when it is projected to reach USD 1.03 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 0.78 Billion in 2024.

SOURCE: We Market Research

Filgrastim, a colony-stimulating factor drug, increases white blood cell production in the bone marrow, particularly neutrophils. Neutrophils, which are essential for fighting infections, can decrease during chemotherapy, resulting in neutropenia. Filgrastim is critical in lowering infection risks in these patients by increasing neutrophil counts. It has applications in a variety of settings, including bone marrow transplants, some malignancies, and myelodysplastic syndrome, where neutropenia is a concern. Filgrastim, which is administered via subcutaneous injection or intravenous infusion, is marketed under the names Neupogen, Zarxio, Grastofil, and Nivestim, and it provides a lifeline to people who have reduced immune function.

Numerous reasons are driving the worldwide filgrastim market. Growing cancer rates increase the need for filgrastim, which is essential for treating neutropenia brought on by chemotherapy. Market growth is supported by its expanding uses, which include treating illnesses like myelodysplastic syndrome. Enhancing accessibility is made possible by better healthcare infrastructure, particularly in rising economies. Demand is further increased as the population ages and more disorders that need Filgrastim become prevalent. The market reach of Filgrastim is increased by raising awareness of the dangers of neutropenia and its function. Strategic partnerships, technical advancements, supportive legislative frameworks, and healthcare reforms all make major contributions. Furthermore, the patent expiration of branded items increases accessibility and competition, which drives further market growth.

Market Scope

Report Attributes


Market Size in 2024

USD 0.78 Billion

Market Forecast in 2034

USD 1.03 Billion

CAGR % 2024-2034


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Type, By Application, By Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria


Carmustine Industry: Dynamics & Restrains

Market opportunity:


We Market Research: Carmustine Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Carmustine Segmentation

Market- By Type Analysis

By Type, the Carmustine Market is Categories into Granulocyte-Colony Stimulating Factor (G-CSF), Long-acting Filgrastim (pegfilgrastim). The Long-acting Filgrastim (pegfilgrastim) segment accounts for the largest share of around 76% in 2024.

Long-acting Filgrastim (pegfilgrastim) is driven by its extended dosing intervals, reducing the frequency of injections compared to standard Filgrastim. This offers convenience to patients undergoing chemotherapy, improving compliance and potentially reducing healthcare costs associated with treatment administration.

The following segments are part of an in-depth analysis of the global Carmustine market:

Market Segments


By   Application

·         Oncology

·         Hematology

·         Other conditions causing neutropenia

By  Distribution Channel

·         Hospital pharmacies

·         Retail pharmacies

·         Online pharmacies

By  End User

·         Specialty Clinics

·         Ambulatory Surgical Centers

·         Cancer Treatment Centers

·         Homecare Settings


Carmustine Industry: Regional Analysis

North America Market Forecast

North America dominate the Carmustine Market with the highest revenue generating market with share of more than 47%. North America's Carmustine market is driven by a high cancer prevalence, technological advancements and high healthcare expenditure in countries like the United States and Canada are propelling the growth of the filgrastim market. Also the prevalence of cancer and other chronic diseases in this region drives the demand for filgrastim-based treatments.

Europe Market Statistics

Europe's Carmustine market benefits from the rising incidence of cancer in Europe increases demand for Carmustine. In Europe, witnessing an increasing demand for biosimilars, including filgrastim, due to patent expirations of branded drugs. Government initiatives promoting the use of biosimilars to reduce healthcare costs and the presence of established pharmaceutical companies focusing on biosimilar production are driving the market in this region.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Carmustine market during the forecast period. In the Asia Pacific, the Filgrastim market thrives due to increasing cancer cases, rising healthcare spending, supportive government policies, a growing elderly population, biotechnological advancements, and extensive clinical research, collectively propelling demand for this vital drug.

Key Market Players

The Filgrastim Market is dominated by a few large companies, such as

·         Amgen

·         SANDOZ INC

·         Teva Pharmaceutical

·         Others

1.      Global Carmustine Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Carmustine Market Scope and Market Estimation

1.2.1. Global Carmustine Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Carmustine Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Product Type of Global Carmustine Market

1.3.2. Application of Global Carmustine Market

1.3.3. Distribution Channel of Global Carmustine Market

1.3.4. Region of Global Carmustine Market

2.      Executive Summary

2.1.    Global Carmustine Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Carmustine Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Carmustine Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Product Type

4.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2019 to 2034

4.1.1. Carmustine for Injection

4.1.2. Implantable Carmustine Wafer

5.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Brain Cancer

5.1.2. Multiple Myeloma

5.1.3. Hodgkin's Lymphoma

5.1.4. Non-Hodgkin's Lymphoma

5.1.5. Other Cancers

6.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Online Pharmacies

7.      Global Carmustine Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Carmustine Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Carmustine Market: Estimates & Forecast Trend Analysis

8.1.    North America Carmustine Market Assessments & Key Findings

8.1.1. North America Carmustine Market Introduction

8.1.2. North America Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By Product Type   By Application   By Distribution Channel   By Country     The U.S.     Canada     Mexico

9.      Europe Carmustine Market: Estimates & Forecast Trend Analysis

9.1.    Europe Carmustine Market Assessments & Key Findings

9.1.1. Europe Carmustine Market Introduction

9.1.2. Europe Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By Product Type   By Application   By Distribution Channel        By Country     Germany     U.K.     France     Italy     Spain     Russia     Rest of Europe

10.  Asia Pacific Carmustine Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Carmustine Market Introduction

10.1.2.   Asia Pacific Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By Product Type    By Application    By Distribution Channel    By Country China Japan India Australia South Korea ASEAN Rest of Asia Pacific

11.  Middle East & Africa Carmustine Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Carmustine Market Introduction

11.1.2.   Middle East & Africa Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By Product Type    By Application    By Distribution Channel    By Country U.A.E. Saudi Arabia Egypt South Africa Rest of Middle East & Africa

12.  South America Carmustine Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Carmustine Market Introduction

12.1.2.   South America Carmustine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By Product Type    By Application    By Distribution Channel    By Country Brazil Argentina Colombia Rest of South America

13.  Competition Landscape

13.1.  Global Carmustine Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Carmustine Market Competition White Space Analysis, By End-user

13.3.  Global Carmustine Market Competition Heat Map Analysis, By End-user

13.4.  Global Carmustine Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Hebei Meitu Pharmaceutical.

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Avet Pharmaceuticals Inc.

14.3.      Bristol Myers Squibb

14.4.      Accord Healthcare

14.5.      Amneal

14.6.      Emcure Pharma

14.7.      Marcan Pharmaceuticals

14.8.      Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Carmustine Market in 2024?

Carmustine Market was valued at USD 0.78 Billion in 2024.

What is the growth rate for the Carmustine Market?

Carmustine Market size will increase at approximate CAGR of 2.84% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Carmustine Market are Amgen, SANDOZ INC,Teva Pharmaceutical and Others.

Which region dominates the Carmustine Market?

North America dominates the market with an active share of 47%.


Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI